Geographic Atrophy: A New Approach to a Historically Untreatable Disease

If you’ve been in #retina long enough, you remember when GA was basically an endpoint. We monitored. We counseled. And that was about it. In this virtual roundtable, Dr. Priya Vakharia joined Dr. David Chin Yee and Dr. Harit Bhattt to talk about how that mindset has shifted and what that actually looks like in clinic today. They discussed: • GA as a chronic disease we can now modify • Why the “right” patient often isn’t the symptomatic one • How to explain slowing progression when patients expect improvement • The real-world burden of treatment and compliance • When to continue… and when to stop These aren’t simple conversations. They’re nuanced. They’re individualized. And they’re happening more and more in our exam lanes. There may not be a visual acuity gain but preserving retinal tissue matters. And at the very least, patients deserve to know they have options. This was an editorially independent series with support from Astellas